165 related articles for article (PubMed ID: 25420472)
1. Crystal structure of Thermobifida fusca Cse1 reveals target DNA binding site.
Tay M; Liu S; Yuan YA
Protein Sci; 2015 Feb; 24(2):236-45. PubMed ID: 25420472
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
[TBL] [Abstract][Full Text] [Related]
3. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution and biochemical characterization of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems.
Xiao Y; Ke A
Methods Enzymol; 2019; 616():27-41. PubMed ID: 30691647
[TBL] [Abstract][Full Text] [Related]
6. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into specific crRNA G-rich sequence binding by Meiothermus ruber Cse2.
Liu S; Yuan Z; Yuan YA
J Struct Biol; 2015 May; 190(2):122-34. PubMed ID: 25791617
[TBL] [Abstract][Full Text] [Related]
8. Cascade-mediated binding and bending of negatively supercoiled DNA.
Westra ER; Nilges B; van Erp PB; van der Oost J; Dame RT; Brouns SJ
RNA Biol; 2012 Sep; 9(9):1134-8. PubMed ID: 22954644
[TBL] [Abstract][Full Text] [Related]
9. The role of Cas8 in type I CRISPR interference.
Cass SD; Haas KA; Stoll B; Alkhnbashi OS; Sharma K; Urlaub H; Backofen R; Marchfelder A; Bolt EL
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182359
[TBL] [Abstract][Full Text] [Related]
10. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
Majsec K; Bolt EL; Ivančić-Baće I
BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
[TBL] [Abstract][Full Text] [Related]
11. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system.
Koo Y; Ka D; Kim EJ; Suh N; Bae E
J Mol Biol; 2013 Oct; 425(20):3799-810. PubMed ID: 23500492
[TBL] [Abstract][Full Text] [Related]
12. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
13. Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex.
Nimkar S; Anand B
Nucleic Acids Res; 2020 Mar; 48(5):2486-2501. PubMed ID: 31980818
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of CRISPR-RNA guided recognition of DNA targets in Escherichia coli.
van Erp PB; Jackson RN; Carter J; Golden SM; Bailey S; Wiedenheft B
Nucleic Acids Res; 2015 Sep; 43(17):8381-91. PubMed ID: 26243775
[TBL] [Abstract][Full Text] [Related]
15. Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System.
Xiao Y; Luo M; Hayes RP; Kim J; Ng S; Ding F; Liao M; Ke A
Cell; 2017 Jun; 170(1):48-60.e11. PubMed ID: 28666122
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.
Niewoehner O; Jinek M
RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure and CRISPR RNA-binding site of the Cmr1 subunit of the Cmr interference complex.
Sun J; Jeon JH; Shin M; Shin HC; Oh BH; Kim JS
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):535-43. PubMed ID: 24531487
[TBL] [Abstract][Full Text] [Related]
18. DNA interference is controlled by R-loop length in a type I-F1 CRISPR-Cas system.
Tuminauskaite D; Norkunaite D; Fiodorovaite M; Tumas S; Songailiene I; Tamulaitiene G; Sinkunas T
BMC Biol; 2020 Jun; 18(1):65. PubMed ID: 32539804
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
Numata T; Inanaga H; Sato C; Osawa T
J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
[TBL] [Abstract][Full Text] [Related]
20. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3.
Westra ER; van Erp PB; Künne T; Wong SP; Staals RH; Seegers CL; Bollen S; Jore MM; Semenova E; Severinov K; de Vos WM; Dame RT; de Vries R; Brouns SJ; van der Oost J
Mol Cell; 2012 Jun; 46(5):595-605. PubMed ID: 22521689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
